G. Coope

Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats

C. Allott, M. Coghlan, D. Mckerrecher, 2006, British journal of pharmacology.

Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models

R. Newman, J. Grosse, H. Cox, 2015, Diabetes.

Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes

B. Leighton, G. Coope, A. Atkinson, 2014, British journal of pharmacology.

Identification of pyrazolo-pyrimidinones as GHS-R1a antagonists and inverse agonists for the treatment of obesity

Nathaniel G. Martin, Robert D. M. Davies, P. Macfaul, 2013 .

The oDGal Mouse: A Novel, Physiologically Relevant Rodent Model of Sporadic Alzheimer’s Disease

P. Maycox, C. Thiemermann, Stuart Maudsley, 2023, International journal of molecular sciences.